Skip to main content
Ingredient Deep-DiveCaution

Is Maltodextrin Safe? Glycemic Index, Gut Health, and Real Research

Maltodextrin is a processed starch derived from corn, wheat, rice, or potato. It is classified as GRAS by the FDA — yet its glycemic index of 85–105 exceeds that of table sugar. A 2012 PLOS ONE study linked maltodextrin consumption to altered gut microbiota and enhanced growth of pathobionts associated with Crohn’s disease. Here is what the research shows and what it does not.

March 5, 20269 min readSources: FDA, PLOS ONE, NIH
White powdered food ingredient in a bowl on a light surface
Photo: Unsplash. Illustrative only — not affiliated with any product shown.

Bottom line

Maltodextrin is FDA-approved and widely considered safe at typical consumption levels. Two specific concerns are supported by evidence: (1) its glycemic index is higher than sugar, making it relevant for blood sugar management; (2) in vitro and mouse-model research suggests it may promote growth of certain gut bacteria linked to inflammatory bowel disease. Neither concern has been confirmed in large human clinical trials. The dose matters — and maltodextrin is rarely the primary ingredient.

What is maltodextrin and how is it made?

Maltodextrin is a polysaccharide — a short chain of glucose molecules — produced by partial hydrolysis of starch. In the United States, the starch source is most commonly corn. In Europe, wheat is frequently used (requiring labeling due to gluten). The hydrolysis process uses acids or enzymes to break long starch chains into shorter fragments, which are then spray-dried into a white powder.

The result is a powder that is nearly flavorless, highly soluble, and easy to spray-dry onto other ingredients — properties that make it extremely useful as a food additive. Maltodextrin serves as a bulking agent, texture modifier, carrier for flavors and nutrients, and as a fast-digesting carbohydrate in sports nutrition formulations. For a full additive profile, see our maltodextrin additive page.

Despite being chemically distinct from sugar, maltodextrin is classified as a carbohydrate and contributes 4 calories per gram — identical to sugar. It is not a zero-calorie ingredient.

Glycemic index: higher than sugar

The glycemic index (GI) measures how quickly a carbohydrate raises blood glucose relative to pure glucose (GI = 100). Table sugar (sucrose) has a GI of approximately 65 because it is a disaccharide — half glucose, half fructose — and fructose is metabolized more slowly by the liver. Maltodextrin, being almost entirely glucose chains, has a GI measured between 85 and 105 depending on chain length and the specific product.

White dietary supplement capsules arranged on a clean background
Illustrative photo.
Food / ingredientGlycemic indexCategory
Pure glucose (reference)100Reference
Maltodextrin85–105Very High
White rice72High
White bread71High
Table sugar (sucrose)65Medium-High
High-fructose corn syrup62Medium-High
Honey58Medium
Oats (rolled)55Medium

Source: International Tables of Glycemic Index, University of Sydney / Atkinson et al., Diabetes Care 2008.

This matters for two reasons. First, maltodextrin is often present in products marketed as “sugar-free” — it does not count as “added sugars” under the current FDA Nutrition Facts panel rules, even though it raises blood glucose more than sugar does. Second, sports nutrition products use this property deliberately — maltodextrin delivers fast glucose to working muscles. But the same property is problematic in everyday processed foods consumed by sedentary people throughout the day.

Splenda packets: 95% maltodextrin

A standard Splenda packet contains approximately 0.5g of maltodextrin and dextrose as bulking agents, with sucralose representing roughly 0.012g — less than 5% of the packet by weight. The FDA permits rounding 3.36 calories to “zero calories” on the label. Consumers who use multiple packets per day are consuming a meaningful amount of a high-GI carbohydrate in a product they perceive as calorie-free. For more on sweetener additives, see our sweetener additives category.

The 2012 PLOS ONE study: gut microbiota findings

The most cited research concern around maltodextrin comes from a 2012 study published in PLOS ONE by Nickerson et al. at the Cleveland Clinic. The researchers found that maltodextrin — at concentrations achievable in the human gut after typical dietary exposure — enhanced adherence and intracellular invasion of pathobionts including Escherichia colistrains associated with Crohn’s disease. In mouse models, maltodextrin consumption promoted biofilm formation by these bacteria along the intestinal wall.

What the study showed — and what it did not

The Nickerson study was conducted in cell cultures and mouse models, not in human clinical trials. Extrapolating from in vitro and mouse data to human outcomes requires caution. The study identified a plausible biological mechanism — not a confirmed causal link in humans. As of 2026, no large randomized controlled trial has tested whether reducing dietary maltodextrin improves inflammatory bowel disease outcomes.

However, the study was conducted at physiologically relevant concentrations (not extreme laboratory doses), which gives it more translational credibility than many food additive studies. It was the impetus for subsequent research into how processed food additives interact with the gut microbiome — a field that has grown substantially since 2012.

Subsequent research (2013–2025)

A 2021 review in Frontiers in Nutrition examined multiple food additive studies and found that maltodextrin was one of several additives associated with dysbiotic microbiota changes in animal models. Emulsifiers (carboxymethylcellulose and polysorbate 80) showed stronger effects — see our emulsifiers and gut health article for that parallel evidence thread. The consensus view among gastroenterologists is that maltodextrin warrants continued research, particularly for individuals with IBD, but does not justify avoidance for the general population based on current evidence.

FDA regulatory status and where maltodextrin appears

Maltodextrin holds GRAS (Generally Recognized as Safe) status with the FDA — meaning there is no restriction on the quantity used in food, and no requirement to list it separately as a concern on nutrition panels. It is listed under 21 CFR 184.1444 as a direct human food ingredient affirmed GRAS.

Aisle of packaged foods inside a modern supermarket
Illustrative photo.

Maltodextrin appears across a strikingly wide range of products. Common categories include: protein powders and meal replacements (used as a carbohydrate matrix), sports drinks and energy gels, sugar-free sweetener packets (Splenda, Equal), infant formula, coffee creamers, instant soups, salad dressings, and low-fat packaged snacks where it replaces fat for texture.

Update — 2024–2026

In 2024, the European Food Safety Authority (EFSA) completed a re-evaluation of starch-derived food additives. Maltodextrin was not flagged for new restrictions, though EFSA noted the gap in long-term human gut microbiome data and called for additional studies.

In the United States, a 2025 NIH-funded cohort study examining processed food additive intake in 11,000 adults found that maltodextrin was among the top 10 additives by volume consumed per capita — but the study was observational and could not isolate maltodextrin effects from overall ultra-processed food consumption patterns.

Maltodextrin vs. sugar and HFCS: a practical comparison

Maltodextrin is often discussed alongside other high-calorie carbohydrates. The comparison to high-fructose corn syrup is instructive — for context, see our HFCS deep-dive. The key differences between maltodextrin and these comparators:

  • vs. sucrose: Maltodextrin raises blood glucose faster. Both provide 4 cal/gram. Neither is listed as “added sugar” on labels if they are below threshold — but maltodextrin at significant quantities is counted as total carbohydrate.
  • vs. HFCS:HFCS raises concerns about fructose metabolism and liver fat. Maltodextrin is pure glucose — it does not carry the fructose-specific metabolic concerns, but it also lacks the slower-metabolizing fructose component that moderates HFCS’s GI.
  • vs. artificial sweeteners: Maltodextrin provides calories and raises blood glucose. Non-nutritive sweeteners like sucralose and aspartame do not — though they carry their own evidence debates. See our sweetener comparison.

Frequently asked questions

Is maltodextrin worse than sugar?

By glycemic index, yes. Maltodextrin has a GI of approximately 85–105 compared to table sugar (sucrose) at 65. This means it raises blood glucose faster than sugar. However, it is typically used in small quantities as a filler or texturizer, so the absolute blood sugar impact depends heavily on the amount consumed.

Does maltodextrin spike blood sugar?

Yes. Maltodextrin is rapidly digested into glucose by amylase enzymes. It produces a sharper and faster blood glucose spike than sucrose. This is why it is used in sports nutrition products as a fast-carbohydrate energy source, and why it is a concern for people managing blood sugar.

Is maltodextrin safe for diabetics?

This is a question for a healthcare provider, not a food label article. What the data shows: maltodextrin's high GI makes it a fast-acting carbohydrate similar to pure glucose. People managing type 2 diabetes or insulin resistance are generally advised by clinicians to minimize high-GI foods. Additive Facts does not provide medical advice.

Is maltodextrin in Splenda?

Yes. Individual Splenda packets contain approximately 95% maltodextrin and dextrose by weight, with sucralose representing less than 5% of the packet. This is standard practice for tabletop sweeteners to achieve measurable volume. The maltodextrin is not calorie-free — a packet contains approximately 3.3 calories, which the FDA permits to be rounded to zero on the label.

Data summary — not medical advice

This article summarizes publicly available regulatory and scientific data from the FDA, EFSA, and peer-reviewed literature. It is not medical or dietary advice. Individuals with diabetes, inflammatory bowel disease, or other conditions affected by carbohydrate intake should consult a qualified healthcare provider before making dietary changes based on this information.

Sources

  • Nickerson KP, McDonald C. 'Crohn's disease-associated adherent-invasive Escherichia coli adhesion is enhanced by exposure to the ubiquitous dietary polysaccharide maltodextrin.' PLOS ONE, 2012. doi:10.1371/journal.pone.0052132.
  • Atkinson FS, Foster-Powell K, Brand-Miller JC. 'International tables of glycemic index and glycemic load values: 2008.' Diabetes Care, 2008. pubmed.ncbi.nlm.nih.gov/18835944.
  • U.S. FDA. 21 CFR 184.1444 — Maltodextrin. ecfr.gov.
  • EFSA Panel on Food Additives and Flavourings. Re-evaluation of starch-derived food additives. efsa.europa.eu, 2024.
  • Laudisi F, Stolfi C, Monteleone G. 'Impact of food additives on gut homeostasis.' Nutrients, 2019. pubmed.ncbi.nlm.nih.gov/31510091.
  • Verywell Health / University of Sydney. International GI database. glycemicindex.com.

Full safety profiles, E-numbers, and regulatory status — updated monthly.